ESR1 and breast carcinoma: For example, one of the first gene panels derived from microarray experiments is the 70 gene signature (70-GS), so-called MammaPrintTM assay, that was developed for breast cancer diagnostics and prognostics intended for individualized treatment of estrogen receptor (ER)+/−, lymph-node (−) patients8.